Search

Lynette F. Smith

Examiner (ID: 15310)

Most Active Art Unit
1813
Art Unit(s)
1648, 1806, 1661, 1813, 1645, 1649
Total Applications
356
Issued Applications
174
Pending Applications
30
Abandoned Applications
152
Applications
StatisticsSubscription-Only

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 3506745 [patent_doc_number] => 05562905 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-08 [patent_title] => 'Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals' [patent_app_type] => 1 [patent_app_number] => 7/324027 [patent_app_country] => US [patent_app_date] => 1989-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 10613 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/562/05562905.pdf [firstpage_image] =>[orig_patent_app_number] => 324027 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/324027 		Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals Mar 19, 1989 Issued
Array ( [id] => 2849750 [patent_doc_number] => 05133960 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-07-28 [patent_title] => 'Use of TNF and LT for the preparation of drugs' [patent_app_type] => 1 [patent_app_number] => 7/296144 [patent_app_country] => US [patent_app_date] => 1989-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 574 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/133/05133960.pdf [firstpage_image] =>[orig_patent_app_number] => 296144 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/296144 		Use of TNF and LT for the preparation of drugs Jan 11, 1989 Issued
07/290497 PHARMACEUTICAL COMPOSITIONS AND USE THEREOF IN THE TREATMENT OF PSORIASIS Dec 26, 1988 Abandoned
07/286477 MONOCLONAL ANTIBODIES TO CACHECTIN/TUMOR NECROSIS FACTOR AND METHODS FOR PREPARING SAME Dec 18, 1988 Abandoned
07/282606 PROTEOLYTIC FRAGMENTS OBTAINED FROM HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN COMPLEX I Dec 11, 1988 Abandoned
07/275309 SYNTHETIC DNA DERIVED RECOMBINANT HIV ANTIGENS Nov 22, 1988 Abandoned
07/269407 CONSTRUCTION OF NON-INFECTIOUS RETROVIRAL MUTANTS DEFICIENT IN VIRAL RNA Nov 9, 1988 Abandoned
07/268322 HIV-2 ENVELOPE POLYPEPTIDES Nov 6, 1988 Abandoned
07/244590 ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) VIRAL ENVELOPE PROTEIN AND METHOD OF TESTING FOR AIDS Sep 12, 1988 Abandoned
07/238937 MACROPHAGE-DERIVED INFLAMMATORY MEDIATOR (MIP-1ALPHA AND MIP 1BETA) Sep 1, 1988 Abandoned
07/239775 VACCINE TO CONTROL THE VIRAL INFECTION OF FISH Sep 1, 1988 Abandoned
07/227568 MOLECULARLY CLONED ACQUIRED IMMUNODEFICIENCY SYNDROME POLYPEPTIDES AND THEIR METHODS OF USE Aug 1, 1988 Abandoned
07/200752 PREVENTION AND TREATMENT OF RETROVIRAL DISEASE May 30, 1988 Abandoned
07/168088 HIV SUBUNIT VACCINE Mar 10, 1988 Abandoned
07/162781 METHOD OF TREATING AUTOIMMUNE AND/OR VIRAL-INDUCED DISEASES THAT ARE MEDIATED BY CD8 PHENOTYPE T CELLS Mar 1, 1988 Abandoned
07/148692 SYNTHETIC ANTIGEN EVOKING ANTI-HIV RESPONSE Jan 25, 1988 Abandoned
07/126007 PRODUCTION OF HUMAN T-CELL LEUKEMIA (LYMPHOTROPIC) RETROVIRUS (HTLV-I) ENVELOPE PROTEIN FRAGMENTS IN BACTERIAL AND USE IN SEROEPIDEMIOLOGICAL STUDIES Nov 26, 1987 Abandoned
07/034874 MONOCLONAL ANTIBODIES RECOGNIZING HUMAN INTERLEUKIN-2-RECEPTOR Apr 5, 1987 Abandoned
06/751771 NOVEL COMPOSITIONS AND METHODS FOR VIRAL VACCINATION Jul 1, 1985 Abandoned
06/358150 FATTY ACID CARRIERS FOR SYNTHETIC VACCINES Mar 14, 1982 Abandoned
Menu